Clinical Trials List
2023-02-01 - 2026-12-31
Phase II
Recruiting5
ICD-10K70.0
Alcoholic fatty liver
ICD-9571.0
Alcoholic fatty liver
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李晏榮 Division of Endocrinology
- 陳博煥 Digestive System Department
- 鄭雅婷 Digestive System Department
- Chung-Wei Su Digestive System Department
- 陳怡文 Division of Endocrinology
- Wen-Juei Jeng Digestive System Department
- Rong-Nan Chien Digestive System Department
- 林伯庭 Digestive System Department
- 劉彥君 Digestive System Department
- 賴盈傑 Division of Radiology
- Chun-Yen Lin Digestive System Department
- 滕威 Digestive System Department
- 戴達英 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jee-Fu Huang Digestive System Department
- Chia-Yen Dai Digestive System Department
- Wan-Long Chuang Digestive System Department
- Ming-Lun Yeh Digestive System Department
- Chung-Feng Huang Digestive System Department
- 梁博程 Digestive System Department
- 黃駿逸 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 簡世杰 未分科
- Chiu Hung Chiu 未分科
- 邱彥程 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chin-Sung Kuo 未分科
- I-Cheng Lee Digestive System Department
- 李癸汌 Digestive System Department
- 王苑貞 Digestive System Department
- 黃惠君 Digestive System Department
- Pei-Chang Lee Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
318 participants